Triglycerides, Total Cholesterol, and Body Weight Index Demonstrates High Discriminative Performance for Metabolic Syndrome: A Comparative Study with Established Cardiometabolic and Inflammatory Indices
Current Research in Health Sciences · 2026
DOI: 10.62425/crihs.1977684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Research in Health Sciences, 2026. Verfasst von Mehmet Erdem und 3 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Gefördert von: The authors declared that this study has received no financial support..
Abstract (Originalsprache)
Objective
This research sought to assess the effectiveness of combined inflammatory and cardiometabolic markers, with a particular focus on the triglycerides, total cholesterol, and body weight index (TCBI), in individuals diagnosed with metabolic syndrome (MetS).
Methods
This retrospective, single-center study included individuals aged 18-65 years who were admitted to the internal medicine clinic between January 2023 and January 2026. MetS was defined according to NCEP ATP III criteria. Demographic, anthropometric, and laboratory data were obtained from electronic medical records. In addition to routine biochemical and hematological parameters, composite indices including TCBI, TyG, CMI, CRP/HDL, NHR, UHR, NLAR, PIV, HALP, NLR, SIRI, and SII were calculated using standard formulas. Appropriate statistical tests were utilized to compare groups. To evaluate the diagnostic effectiveness of the indices, a ROC curve analysis was performed.
Results
Several anthropometric and metabolic parameters differed significantly between groups (p < 0.05). Among the evaluated indices, TCBI, CMI, TyG, CRP/HDL, NHR, and UHR levels were significantly elevated in MetS patients (p < 0.0001), whereas NLAR, PIV, HALP, NLR, SIRI, and SII showed no significant differences (p > 0.05). ROC analysis demonstrated that TCBI had the highest diagnostic performance (AUC: 0.9622, 95% CI: 0.9378 - 0.9865, p < 0.0001), followed by CMI (AUC: 0.9600) and TyG (AUC: 0.9463). CRP/HDL, NHR, and UHR exhibited moderate discriminative ability.
Conclusion
TCBI showed strong diagnostic performance in this cohort and demonstrated higher overall discriminative ability compared with the evaluated indices. These findings suggest that TCBI may represent a simple and accessible marker for MetS assessment. However, further studies are required to validate its clinical utility.
Förderung
- The authors declared that this study has received no financial support.
Zitieren
APA
Erdem, M., Kıran, T. R., Keskin, L., & Karahan, S. C. (2026). Triglycerides, Total Cholesterol, and Body Weight Index Demonstrates High Discriminative Performance for Metabolic Syndrome: A Comparative Study with Established Cardiometabolic and Inflammatory Indices. Current Research in Health Sciences. https://doi.org/10.62425/crihs.1977684
Vancouver
Erdem M, Kıran TR, Keskin L, Karahan SC. Triglycerides, Total Cholesterol, and Body Weight Index Demonstrates High Discriminative Performance for Metabolic Syndrome: A Comparative Study with Established Cardiometabolic and Inflammatory Indices. Current Research in Health Sciences. 2026. doi:10.62425/crihs.1977684
BibTeX
@article{Erdem2026,
author = {Erdem, Mehmet and Kıran, Tuğba Raika and Keskin, Lezan and Karahan, Süleyman Caner},
title = {Triglycerides, Total Cholesterol, and Body Weight Index Demonstrates High Discriminative Performance for Metabolic Syndrome: A Comparative Study with Established Cardiometabolic and Inflammatory Indices},
journal = {Current Research in Health Sciences},
year = {2026},
doi = {10.62425/crihs.1977684}
}
EUVIMED